Interpace Biosciences, Inc.

OTCPK:IDXG Stock Report

Market Cap: US$11.8m

Interpace Biosciences Management

Management criteria checks 4/4

Interpace Biosciences' CEO is Tom Burnell, appointed in Dec 2020, has a tenure of 3.92 years. total yearly compensation is $678.41K, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 1.86% of the company’s shares, worth $218.65K. The average tenure of the management team and the board of directors is 2.8 years and 4.8 years respectively.

Key information

Tom Burnell

Chief executive officer

US$678.4k

Total compensation

CEO salary percentage64.2%
CEO tenure3.9yrs
CEO ownership1.9%
Management average tenure2.8yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Interspace Biosciences trades high, appoints new finance chief

Feb 04

Interpace signs licensing agreement for monoclonal antibody platform Das-1

Feb 01

CEO Compensation Analysis

How has Tom Burnell's remuneration changed compared to Interpace Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$5m

Jun 30 2024n/an/a

US$3m

Mar 31 2024n/an/a

US$1m

Dec 31 2023US$678kUS$436k

US$1m

Sep 30 2023n/an/a

-US$1m

Jun 30 2023n/an/a

-US$2m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022US$634kUS$434k

-US$6m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$4m

Dec 31 2021US$588kUS$425k

-US$7m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$24m

Dec 31 2020US$935kUS$35k

-US$29m

Compensation vs Market: Tom's total compensation ($USD678.41K) is about average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.

CEO

Tom Burnell (62 yo)

3.9yrs

Tenure

US$678,407

Compensation

Dr. Thomas W. Burnell, also known as Tom, Ph.D. serves as the President, Chief Executive Officer and Director at Interpace Biosciences, Inc. since December 01, 2020 and serves as its Chairman from February...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Burnell
President3.9yrsUS$678.41k1.86%
$ 218.6k
Christopher McCarthy
Chief Financial Officer1.6yrsUS$332.04k1.04%
$ 122.2k
Sydney Finkelstein
Chief Scientific Officerno datano datano data
Jody Campbell
Chief Revenue Officer2.8yrsno datano data
Nicole Massoll
Chief Medical Officerless than a yearno datano data
Patrick Kane
VP & Corporate Controller15.4yrsno datano data

2.8yrs

Average Tenure

Experienced Management: IDXG's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Thomas Burnell
President3.9yrsUS$678.41k1.86%
$ 218.6k
Joseph Keegan
Independent Director8.8yrsUS$50.00k0.040%
$ 4.7k
Stephen Sullivan
Independent Director20.2yrsUS$62.50k0.056%
$ 6.6k
Vijay Aggarwal
Independent Director2.8yrsUS$50.00k0%
$ 0
Fortunato Rocca
Independent Director4.8yrsUS$40.00k0%
$ 0

4.8yrs

Average Tenure

70yo

Average Age

Experienced Board: IDXG's board of directors are considered experienced (4.8 years average tenure).